Alnylam Pharmaceuticals, Inc.

AVIVA PLC ALNY
Report date
6/30/2026
Quarter
2026 Q2
Filed
8/13/2026
Shares
114,532
Value ($000)
34,478
Weight
0.1%
2019 Q4 - 2026 Q2 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).